Innoviva (INVA) Invested Capital (2010 - 2025)

Innoviva (INVA) posted Invested Capital of $191.9 million for Q2 2025, little changed on a QoQ basis from $192.2 million in Q1 2025.

Innoviva (INVA) Invested Capital (2010 - 2025) Analysis & Trends

Innoviva's Invested Capital history runs 14 years deep, the most recent figure standing at $191.9 million for Q2 2025.

Quarterly Invested Capital changed N/A year-over-year to $191.9 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $191.9 million (down 66.69% YoY) and the FY2024 annual result came in at $192.0 million, changed N/A from the prior year.
Invested Capital was $191.9 million for Q2 2025 at Innoviva, roughly flat from $192.2 million in the prior quarter.
Across five years, Invested Capital topped out at $433.5 million in Q2 2021 and bottomed at $96.0 million in Q1 2022.
A 4-year average of $201.9 million and a median of $191.9 million in 2024 frame the typical range for Invested Capital.
Annual changes were most pronounced in 2021 — Invested Capital changed 0.0% — and 2022, when it tumbled 77.84%.
Innoviva's Invested Capital stood at $433.5 million in 2021, then tumbled by 77.81% to $96.2 million in 2022, then jumped by 99.63% to $192.0 million in 2024, then fell by 0.07% to $191.9 million in 2025.
Business Quant data shows INVA's Invested Capital at $191.9 million in Q2 2025, $192.2 million in Q1 2025, and $192.0 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	110.96 Mn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	116.14 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Innoviva	1.57 Bn	969.11 Mn	75.83 Mn	-

Download Data